Secreted human apolipoprotein(a) kringle IV-10 and kringle V inhibit angiogenesis and xenografted tumor growth

Biological Chemistry

Volumn 389, Issue 2, 2008, Pages 135-141

  Shen, Le ^a   Zhu, Xuewei ^a   Wang, Yan ^a   Zeng, Wuwei ^a   Wu, Gang ^a   Xue, Hong ^a   Chen, Baosheng ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Angiogenesis; Apolipoprotein(a); Kringle; Secretion; Tumor growth

Indexed keywords

APOLIPOPROTEIN; HYBRID PROTEIN; PROTEIN KRINGLE IV 10; PROTEIN KRINGLE V; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; UMBILICAL VEIN;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; APOLIPOPROTEINS A; CELL LINE, TUMOR; CHICK EMBRYO; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; HUMANS; KRINGLES; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT FUSION PROTEINS; TRANSPLANTATION, HETEROLOGOUS;

PICHIA PASTORIS;

EID: 38649089808     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.016     Document Type: Article

References (23)

1. Auguste, P., Lemiere, S., Larrieu-Lahargue, F., and Bikfalvi, A. (2005). Molecular mechanisms of tumor vascularization. Crit. Rev. Oncol. Hematol. 54, 53-61.
2. Cao, Y., Chen, A., An, S.S., Ji, R.W., Davidson, D., and Llinas, M. (1997). Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272, 22924-22928.
3. Carmeliet, P. (2005). Angiogenesis in life, disease and medicine. Nature 438, 932-936.
4. Cebe-Suarez, S., Zehnder-Fjallman, A., and Ballmer-Hofer, K. (2006). The role of VEGF receptors in angiogenesis; complex partnerships. Cell Mol. Life Sci. 63, 601-615.
5. Coultas, L., Chawengsaksophak, K., and Rossant, J. (2005). Endothelial cells and VEGF in vascular development. Nature 438, 937-945.
6. Cross, M.J. and Claesson-Welsh, L. (2001). FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 22, 201-207.
7. Eliceiri, B.P. and Cheresh, D.A. (2001). Adhesion events in angiogenesis. Curr. Opin. Cell Biol. 13, 563-568.
8. Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186.
9. Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31.
10. Kim, H.K., Lee, S.Y., Oh, H.K., Kang, B.H., Ku, H.J., Lee, Y., Shin, J.Y., Hong, Y.K., and Joe, Y.A. (2003a). Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator. Biochem. Biophys. Res. Commun. 304, 740-746.
11. Kim, J.S., Chang, J.H., Yu, H.K., Ahn, J.H., Yum, J.S., Lee, S.K., Jung, K.H., Park, D.H., Yoon, Y., Byun, S.M., et al. (2003b). Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a). J. Biol. Chem. 278, 29000-29008.
12. Kim, J.S., Yu, H.K., Ahn, J.H., Lee, H.J., Hong, S.W., Jung, K.H., Chang, S.I., Hong, Y.K., Joe, Y.A., Byun, S.M., et al. (2004). Human apolipoprotein(a) kringle V inhibits angiogenesis in vitro and in vivo by interfering with the activation of focal adhesion kinases. Biochem. Biophys. Res. Commun. 313, 534-540.
13. Koschinsky, M.L. and Marcovina, S.M. (2004). Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity. Curr. Opin. Lipidol. 15, 167-174.
14. Kuba, K., Matsumoto, K., Date, K., Shimura, H., Tanaka, M., and Nakamura, T. (2000). HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res. 60, 6737-6743.
15. McLean, J.W., Tomlinson, J.E., Kuang, W.J., Eaton, D.L., Chen, E.Y., Fless, G.M., Scanu, A.M., and Lawn, R.M. (1987). cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330, 132-137.
16. Munoz-Chapuli, R., Quesada, A.R., and Angel Medina, M. (2004). Angiogenesis and signal transduction in endothelial cells. Cell Mol. Life Sci. 61, 2224-2243.
17. O'Reilly, M.S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W.S., Cao, Y., Sage, E.H., and Folkman, J. (1994). Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
18. O'Reilly, M.S., Holmgren, L., Chen, C., and Folkman, J. (1996). Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 2, 689-692.
19. Papetti, M. and Herman, I.M. (2002). Mechanisms of normal and tumor-derived angiogenesis. Am. J. Physiol. Cell Physiol. 282, C947-C970.
20. Pussinen, P.J., Olkkonen, V.M., Jauhiainen, M., and Ehnholm, C. (1997). Molecular cloning and functional expression of cDNA encoding the pig plasma phospholipid transfer protein. J. Lipid Res. 38, 1473-1481.
21. Tang, S., Morgan, K.G., Parker, C., and Ware, J.A. (1997). Requirement for protein kinase C theta for cell cycle progression and formation of actin stress fibers and filopodia in vascular endothelial cells. J. Biol. Chem. 272, 28704-28711.
22. Yu, H.K., Kim, J.S., Lee, H.J., Ahn, J.H., Lee, S.K., Hong, S.W., and Yoon, Y. (2004). Suppression of colorectal cancer liver metastasis and extension of survival by expression of apolipoprotein(a) kringles. Cancer Res. 64, 7092-7098.
23. Yu, H.K., Ahn, J.H., Lee, H.J., Lee, S.K., Hong, S.W., Yoon, Y., and Kim, J.S. (2005). Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination. J. Genet. Med. 7, 39-49.